NOVO.B.DK

429.8

-5.94%↓

GMAB.DK

1,250.5

-2.61%↓

ZEAL.DK

422.2

-8.69%↓

HLUNB.DK

30.24

-5.68%↓

AMBUB.DK

107.85

-1.51%↓

NOVO.B.DK

429.8

-5.94%↓

GMAB.DK

1,250.5

-2.61%↓

ZEAL.DK

422.2

-8.69%↓

HLUNB.DK

30.24

-5.68%↓

AMBUB.DK

107.85

-1.51%↓

NOVO.B.DK

429.8

-5.94%↓

GMAB.DK

1,250.5

-2.61%↓

ZEAL.DK

422.2

-8.69%↓

HLUNB.DK

30.24

-5.68%↓

AMBUB.DK

107.85

-1.51%↓

NOVO.B.DK

429.8

-5.94%↓

GMAB.DK

1,250.5

-2.61%↓

ZEAL.DK

422.2

-8.69%↓

HLUNB.DK

30.24

-5.68%↓

AMBUB.DK

107.85

-1.51%↓

NOVO.B.DK

429.8

-5.94%↓

GMAB.DK

1,250.5

-2.61%↓

ZEAL.DK

422.2

-8.69%↓

HLUNB.DK

30.24

-5.68%↓

AMBUB.DK

107.85

-1.51%↓

Search

Coloplast A-S (Class B)

Gesloten

690.8 -0.78

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

690.6

Max

703.4

Belangrijke statistieken

By Trading Economics

Inkomsten

-270M

1B

Verkoop

73M

7B

K/W

Sectorgemiddelde

33.327

63.778

EPS

6.38

Dividendrendement

3.04

Winstmarge

14.859

Werknemers

16,628

EBITDA

-42M

2.2B

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

+11.86% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

3.04%

2.39%

Volgende Winsten

6 mei 2025

Volgende dividenddatum

14 mei 2025

Volgende Ex Dividend datum

12 mei 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

165B

Vorige openingsprijs

691.58

Vorige sluitingsprijs

690.8

Coloplast A-S (Class B) Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

4 apr 2025, 22:38 UTC

Populaire aandelen

Stocks to Watch: Eli Lilly, Novo Nordisk, Hims & Hers, Maxeon Solar Technologies

5 apr 2025, 09:30 UTC

Winsten

Elon Musk's Mr. Fix-It Takes Center Stage During a Really Bad Week -- WSJ

5 apr 2025, 01:00 UTC

Acquisities, Fusies, Overnames

How BlackRock's Larry Fink Won Over Donald Trump -- WSJ

5 apr 2025, 01:00 UTC

Acquisities, Fusies, Overnames

How BlackRock's Larry Fink Won Over Donald Trump -- WSJ -2-

4 apr 2025, 21:53 UTC

Marktinformatie

Maxeon's Supply Chain Move at Critical Time for Solar Panel Cos -- Market Talk

4 apr 2025, 21:44 UTC

Top Nieuws
Acquisities, Fusies, Overnames

Trump Grants 75-Day Extension to Reach TikTok Deal -- 3rd Update

4 apr 2025, 21:00 UTC

Top Nieuws

Americans Were Souring on Trump's Economic Plans Even Before Tariff Bloodbath -- WSJ

4 apr 2025, 20:52 UTC

Marktinformatie

Peloton Likely to Escape Tariffs Unscathed -- Market Talk

4 apr 2025, 20:52 UTC

Top Nieuws

Trump Can Cut Teacher-Training Programs For Now, Supreme Court Says -- WSJ

4 apr 2025, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

4 apr 2025, 20:48 UTC

Top Nieuws

The Score: Nike, Apple, Stellantis and More Stocks That Defined the Week -- WSJ

4 apr 2025, 20:45 UTC

Top Nieuws

Hiring Defied Expectations in March, With 228,000 New Jobs -- 6th Update

4 apr 2025, 20:32 UTC

Top Nieuws

Dow Tumbles 2,000 Points, Bonds Rally After China Retaliates Against Trump Tariffs -- WSJ

4 apr 2025, 20:21 UTC

Top Nieuws

China Hits Back at Trump With Sweeping Tariffs on All U.S. Goods -- Update

4 apr 2025, 20:00 UTC

Top Nieuws

Republicans March Ahead on Trump's Tax Cuts as Tariffs Kick In -- WSJ

4 apr 2025, 19:51 UTC

Marktinformatie

Dollar Recovers While Recession Fears Grip Wall Street -- Market Talk

4 apr 2025, 19:37 UTC

Top Nieuws

Trump's Team is Getting the Bond Rally It Wanted. But for the Wrong Reasons. -- WSJ

4 apr 2025, 19:32 UTC

Marktinformatie

Oil Selloff Continues as China Responds to U.S. Tariffs -- Market Talk

4 apr 2025, 19:28 UTC

Top Nieuws

U.S. Stocks Fall Further After China Retaliates Against Trump Tariffs -- Update

4 apr 2025, 19:15 UTC

Marktinformatie

Costco Gold, Membership Fees Could Help Cushion from Tariff Costs -- Market Talk

4 apr 2025, 19:12 UTC

Top Nieuws

Powell Warns of Higher Prices, Weaker Growth After Tariff Plan -- 3rd Update

4 apr 2025, 19:11 UTC

Marktinformatie

U.S. Natural Gas Falls as Global Selloff Continues -- Market Talk

4 apr 2025, 19:09 UTC

Marktinformatie

Mexican Stocks, Peso Tumble as Global Rout Continues -- Market Talk

4 apr 2025, 19:09 UTC

Top Nieuws

Trump Grants 75-Day Extension to Reach TikTok Deal -- Second Update

4 apr 2025, 19:00 UTC

Marktinformatie

Fed Has Limited Options to Counter Tariffs -- Market Talk

4 apr 2025, 18:53 UTC

Marktinformatie

Brace for Trump's Tariff Order to Remain in Place for Extended Period -- Market Talk

4 apr 2025, 18:51 UTC

Marktinformatie

Morgan Stanley Analysts Outline Paths to Recession -- Market Talk

4 apr 2025, 18:44 UTC

Marktinformatie

Market Talk Roundup: Latest on U.S. Politics

4 apr 2025, 18:44 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

4 apr 2025, 18:44 UTC

Marktinformatie

Tariffs Won't Achieve What Trump Wants, Morgan Stanley Says -- Market Talk

Peer Vergelijking

Prijswijziging

Coloplast A-S (Class B) Prognose

Koersdoel

By TipRanks

11.86% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 901.38 DKK  11.86%

Hoogste 1,056 DKK

Laagste 720 DKK

Gebaseerd op 8 Wall Street-analisten die 12-maands prijsdoelen bieden voor Coloplast A-S (Class B) - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

8 ratings

2

Buy

4

Hold

2

Sell

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.